Systematic review of the prevalence of current smoking among hospitalized COVID-19 patients in China: could nicotine be a therapeutic option? Reply

Intern Emerg Med. 2021 Jan;16(1):235-236. doi: 10.1007/s11739-020-02457-2. Epub 2020 Sep 21.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • COVID-19*
  • China / epidemiology
  • Humans
  • Nicotine*
  • Prevalence
  • SARS-CoV-2
  • Smoking

Substances

  • Nicotine